Organization and Description of Business - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
Jan. 09, 2024 |
May 06, 2026 |
Mar. 31, 2026 |
Dec. 31, 2025 |
|---|---|---|---|---|
| Common stock, par value | $ 0.001 | $ 0.001 | ||
| Merger Agreement with Angelini Pharma S.p.A. [Member] | Subsequent Event [Member] | ||||
| Common stock, par value | $ 0.001 | |||
| Merger right to receive cash price per share | $ 31.5 | |||
| Public Offering [Member] | ||||
| Stock Issued During Period, Shares, New Issues | 10 | |||
| Proceeds from issuance of common stock | $ 140.7 |
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|